D57.419 Sickle-cell thalassemia, unspecified, with crisis

Name of the Condition

• Sickle-cell thalassemia, unspecified, with crisis

Summary

Sickle-cell thalassemia, unspecified, with crisis is a genetic blood disorder resulting from the co-inheritance of sickle cell disease and thalassemia mutations. It causes red blood cells to become abnormal in shape and function, leading to complications such as anemia, pain, and organ damage. The presence of crisis indicates an acute phase with vaso-occlusive episodes.

Causes

Sickle-cell thalassemia arises from co-inheritance of mutations in the hemoglobin gene (HBB). One parent contributes a sickle cell mutation, while the other contributes a thalassemia mutation. This combination alters hemoglobin structure, resulting in sickle-shaped red blood cells and reduced hemoglobin production.

Risk Factors

• Family history of sickle-cell disease or thalassemia
• Ethnic backgrounds with higher prevalence of these conditions (e.g., Mediterranean, Middle Eastern, Indian, or African descent)
• Inheriting one sickle cell gene and one thalassemia gene increases the risk of passing the disorder to offspring

Symptoms

• Fatigue and weakness due to anemia
• Jaundice (yellowing of the skin or eyes)
• Swelling in hands and feet (dactylitis)
• Frequent infections
• Delayed growth or puberty in children
• Episodes of severe pain (vaso-occlusive crises)

Diagnosis

Diagnosis involves blood tests to identify abnormal hemoglobin, genetic testing to confirm mutations, and clinical evaluation of symptoms. Hemoglobin electrophoresis or high-performance liquid chromatography (HPLC) may detect the specific hemoglobin variants. Family history and ethnic background are also considered.

Treatment Options

Treatment focuses on managing symptoms and preventing complications. This includes pain management during crises, hydration, blood transfusions for severe anemia, hydroxyurea to reduce crisis frequency, and antibiotics for infections. Regular monitoring and vaccinations are recommended.

Prognosis and Follow-Up

Prognosis varies based on severity and complications. Regular follow-up with a hematologist is essential to monitor organ function, manage anemia, and adjust treatment. Early intervention can reduce crisis frequency and improve quality of life.

Complications

• Acute chest syndrome (respiratory distress)
• Stroke or neurological damage
• Organ damage (e.g., spleen, kidneys, liver)
• Splenic sequestration (pooling of sickled cells in the spleen)
• Chronic pain and fatigue

Lifestyle & Prevention

• Stay hydrated to reduce crisis risk
• Avoid extreme temperatures
• Manage stress and get adequate rest
• Follow vaccination schedules to prevent infections
• Avoid smoking and excessive alcohol consumption

When to Seek Professional Help

Seek immediate medical attention for severe pain, difficulty breathing, high fever, or signs of stroke (e.g., sudden weakness, confusion). Regular check-ups are necessary to monitor for complications.

Tips for Medical Coders

Use this code for cases of sickle-cell thalassemia with acute crisis. Document the presence of vaso-occlusive episodes or other crisis-related symptoms. Ensure specificity in clinical notes to support the diagnosis and justify coding.